MDT
53
-2
ILMN
68
-2
NAVI
40
5
AMAT
50
-2
AVB
30
-2
INTU
63
7
EOG
32
-14
PLD
40
-8
AAP
5
-3
EMR
64
-3
CINF
63
-3
PX
62
6
O
35
-7
FOXA
59
-4
SNA
50
-3
MAC
65
-3
VRSK
25
-3
BIIB
46
-3
NSC
59
-3
PBI
53
4
MDT
53
-2
ILMN
68
-2
NAVI
40
5
AMAT
50
-2
AVB
30
-2
INTU
63
7
EOG
32
-14
PLD
40
-8
AAP
5
-3
EMR
64
-3
CINF
63
-3
PX
62
6
O
35
-7
FOXA
59
-4
SNA
50
-3
MAC
65
-3
VRSK
25
-3
BIIB
46
-3
NSC
59
-3
PBI
53
4
Financhill
Back

State Street SPDR SSGA Multi-Asset Real Return ETF Vs. Nektar Therapeutics Industry Stock Comparison

Sell
50

RLY
State Street SPDR SSGA Multi-Asset Real Return ETF

Last Price:
$31.73
Seasonality Move:
-0.51%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$45.42
Seasonality Move:
11.58%
Sell
50
State Street SPDR SSGA Multi-Asset Real Return ETF (RLY) is a Sell

Is State Street SPDR SSGA Multi-Asset Real Return ETF a Buy, Sell or Hold?

  • The current State Street SPDR SSGA Multi-Asset Real Return ETF [RLY] share price is $31.49. The Score for RLY is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • RLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RLY Stock Price Chart

What is State Street SPDR SSGA Multi-Asset Real Return ETF's stock price today?

  • The State Street SPDR SSGA Multi-Asset Real Return ETF share price today is $31.49
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RLY is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

RLY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.18 Buy
Relative Strength Index (14 RSI): 49.48 Sell
Chaikin Money Flow: -56178 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.73 - 61.13) Sell
Bollinger Bands (100): (33.63 - 62.73) Buy

RLY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.74 Sell
20-day SMA: 31.53 Sell
50-day SMA: 31.29 Buy
200-day SMA: 29.63 Buy
8-day EMA: 31.72 Sell
20-day EMA: 31.59 Sell
50-day EMA: 30.7 Buy
200-day EMA: 19.33 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

State Street SPDR SSGA Multi-Asset Real Return ETF Earnings Growth & RLY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

State Street SPDR SSGA Multi-Asset Real Return ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):